Sharp Increase in Hospitalizations Among UK's Young People Due to E-Cigarettes

Regulations by 2FIRSTS.ai

Apr.23.2024

Sharp Increase in Hospitalizations Among UK's Young People Due to E-Cigarettes

E-cigarette-related hospitalizations in UK's under-20s surged 733% in past four years, NHS data reveals. Significant rise in children affected.

According to a report by the New York Post on April 22, the latest data from the UK's National Health Service (NHS) indicates that the number of people under the age of 20 in the UK who have been hospitalized due to e-cigarette use has increased by 733% over the past four years, starting from 2020.

According to statistical data, in 2020, out of 97 cases of hospitalized patients, 19 were children; in 2021, out of 300 hospitalized cases, 19 were children; this number further increased in 2022, with 5 out of 457 cases being children; in 2023, 50 children were hospitalized out of 365 cases, including 11 children under the age of 4.

Furthermore, the report also points out that the number of female patients hospitalized due to e-cigarette-related issues is increasing, growing by 57% compared to 2023.

References:

[1] Child vaping hospitalizations skyrocket 733% — including kids under 5

Also Read:

[1] Wales Plans to Ban Disposable E-cigarettes by 2025

[2] Alarming Increase in Hospitalizations of Children Due to E-Cigarettes

[3] Rising Trend of Smoking Among Affluent Women Under 45

[4] British Government Provides Tax-Free Tobacco to Ukrainian Soldiers Training in the UK

[5] Chill Brands CEO Suspended for Alleged Insider Trading Actions

[6] ELFBAR, LOST MARY Launch Reusable E-Cigarettes in Response to UK Disposable Ban

#Europe #Open system e-cigarettes #UK #Public opinion.

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn

Notice

1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

Copyright

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Altria Q3 2025 Earnings Report: Net Revenue of $6.072 Billion and Launch of on!PLUS in the U.S.

Altria reported Q3 2025 net revenue of $6.072 billion, a 3.0% year-on-year decline. Adjusted EPS increased 3.6% to $1.45. The company expanded its share repurchase program to $2 billion and launched the on!PLUS nicotine pouch in Florida, North Carolina, and Texas.

Oct.31 by 2FIRSTS.ai

Vape Company Takes FDA to Court for Stalling Premarket Decision for Half a Decade

California-based vape manufacturer Schwartz E-Liquid (USA Vape Lab) has sued the U.S. Food and Drug Administration (FDA) in federal court, alleging the agency unlawfully failed to issue a decision on its premarket application for flavored e-cigarette products for more than five years. The company is seeking a court order compelling the FDA to act within 90 days.

Nov.26 by 2FIRSTS.ai

Ireland to Impose EU’s Highest Tax on Vape E-Liquids: €0.50 per ml, Effective Nov. 1

From Nov. 1, Ireland will levy €0.50/ml on all e-liquids and tighten rules—including a disposable ban; advocates warn this could hinder quitting amid a missed 2025 target.

Oct.21 by 2FIRSTS.ai

JT launches half-price Ploom AURA promotion across online and offline channels

Japan Tobacco (JT) has announced a limited-time promotion on selected standard colors of its heated tobacco device Ploom AURA, running from 8 December 2025 to 18 January 2026. During the campaign, the starter kit price will be cut from 2,980 yen (approximately US$19.20) to 1,480 yen (around US$9.53).